{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,20]],"date-time":"2026-11-20T15:34:43Z","timestamp":1795188883221,"version":"4.10.3"},"reference-count":199,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82204704"],"award-info":[{"award-number":["82204704"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Biological Macromolecules"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.ijbiomac.2025.145410","type":"journal-article","created":{"date-parts":[[2025,6,20]],"date-time":"2025-06-20T02:31:26Z","timestamp":1750386686000},"page":"145410","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"P2","title":["Caveolin-1 in prostate Cancer: Novel insights and therapeutic opportunities\u2014A review"],"prefix":"10.1016","volume":"319","author":[{"given":"Tao","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maobin","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tang","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yipeng","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meijun","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peihai","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.ijbiomac.2025.145410_bb0005","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries [J]","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J. Clin."},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.145410_bb0010","doi-asserted-by":"crossref","first-page":"5123","DOI":"10.1038\/s41598-025-88392-8","article-title":"Global burden and risk factors of male cancers from 1990 to 2021, with forecasts to 2040 [J]","volume":"15","author":"Zhang","year":"2025","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.145410_bb0015","first-page":"10","article-title":"Cancer statistics, 2025 [J]","volume":"75","author":"Siegel","year":"2025","journal-title":"CA Cancer J. Clin."},{"issue":"11","key":"10.1016\/j.ijbiomac.2025.145410_bb0020","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1007\/s11912-024-01614-6","article-title":"Prostate Cancer, pathophysiology and recent developments in management: a narrative review [J]","volume":"26","author":"Almeeri","year":"2024","journal-title":"Curr. Oncol. Rep."},{"issue":"5","key":"10.1016\/j.ijbiomac.2025.145410_bb0025","doi-asserted-by":"crossref","first-page":"679","DOI":"10.2967\/jnumed.123.267006","article-title":"Clinical Management of Advanced Prostate Cancer: where does radiopharmaceutical therapy fit in the treatment algorithm? [J]","volume":"65","author":"Viscuse","year":"2024","journal-title":"J. Nucl. Med."},{"issue":"2","key":"10.1016\/j.ijbiomac.2025.145410_bb0030","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.eururo.2024.09.017","article-title":"Management of Patients with Advanced Prostate Cancer. Report from the 2024 Advanced Prostate Cancer Consensus Conference (APCCC) [J]","volume":"87","author":"Gillessen","year":"2025","journal-title":"Eur. Urol."},{"key":"10.1016\/j.ijbiomac.2025.145410_bb0035","first-page":"15(20)","article-title":"Making the Case for Autophagy Inhibition as a Therapeutic Strategy in Combination with Androgen-Targeted Therapies in Prostate Cancer [J]","author":"Elshazly","year":"2023","journal-title":"Cancers (Basel)"},{"issue":"8","key":"10.1016\/j.ijbiomac.2025.145410_bb0040","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1111\/iju.13137","article-title":"Androgen receptor targeted therapies in castration-resistant prostate cancer: bench to clinic [J]","volume":"23","author":"Imamura","year":"2016","journal-title":"Int. J. Urol."},{"key":"10.1016\/j.ijbiomac.2025.145410_bb0045","doi-asserted-by":"crossref","DOI":"10.1177\/17588359241269676","article-title":"Promising therapy for neuroendocrine prostate cancer: current status and future directions [J]","volume":"16","author":"Fei","year":"2024","journal-title":"Ther Adv Med Oncol"},{"issue":"9","key":"10.1016\/j.ijbiomac.2025.145410_bb0050","doi-asserted-by":"crossref","first-page":"7130","DOI":"10.1021\/acs.jmedchem.3c02433","article-title":"Discovery of a potent dual son of Sevenless 1 (SOS1) and epidermal growth factor receptor (EGFR) inhibitor for the treatment of prostate Cancer [J]","volume":"67","author":"Zheng","year":"2024","journal-title":"J. Med. Chem."},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.145410_bb0055","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1186\/s12943-016-0558-7","article-title":"Caveolin-1 in the regulation of cell metabolism: a cancer perspective [J]","volume":"15","author":"Nwosu","year":"2016","journal-title":"Mol. Cancer"},{"issue":"4","key":"10.1016\/j.ijbiomac.2025.145410_bb0060","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1038\/nrc3915","article-title":"Caveolae and signalling in cancer [J]","volume":"15","author":"Martinez-Outschoorn","year":"2015","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.ijbiomac.2025.145410_bb0065","article-title":"Caveolin-1 regulates P2Y(2) receptor signaling during mechanical injury in human 1321N1 astrocytoma [J]","volume":"9(10).doi:10.3390\/biom9100622","author":"Mart\u00ednez","year":"2019","journal-title":"Biomolecules"},{"key":"10.1016\/j.ijbiomac.2025.145410_bb0070","doi-asserted-by":"crossref","DOI":"10.1016\/j.biocel.2022.106307","article-title":"Caveolin-1 signaling-driven mitochondrial fission and cytoskeleton remodeling promotes breast cancer migration [J]","volume":"152","author":"Xiao","year":"2022","journal-title":"Int. J. Biochem. Cell Biol."},{"issue":"9","key":"10.1016\/j.ijbiomac.2025.145410_bb0075","doi-asserted-by":"crossref","first-page":"2092","DOI":"10.1002\/ijc.31369","article-title":"Caveolin-1, cancer and therapy resistance [J]","volume":"143","author":"Ketteler","year":"2018","journal-title":"Int. J. Cancer"},{"issue":"4","key":"10.1016\/j.ijbiomac.2025.145410_bb0080","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1016\/j.apsb.2020.11.020","article-title":"The role of caveolin-1 in the biofate and efficacy of anti-tumor drugs and their nano-drug delivery systems [J]","volume":"11","author":"Yang","year":"2021","journal-title":"Acta Pharm. Sin. B"},{"issue":"8","key":"10.1016\/j.ijbiomac.2025.145410_bb0085","doi-asserted-by":"crossref","first-page":"R402","DOI":"10.1016\/j.cub.2017.11.075","article-title":"Caveolae [J]","volume":"28","author":"Parton","year":"2018","journal-title":"Curr. Biol."},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.145410_bb0090","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1038\/s41556-022-01034-3","article-title":"Caveolin-1 dolines form a distinct and rapid caveolae-independent mechanoadaptation system [J]","volume":"25","author":"Lolo","year":"2023","journal-title":"Nat. Cell Biol."},{"issue":"3","key":"10.1016\/j.ijbiomac.2025.145410_bb0095","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.tcb.2015.10.010","article-title":"Caveolae: one function or many? [J]","volume":"26","author":"Cheng","year":"2016","journal-title":"Trends Cell Biol."},{"key":"10.1016\/j.ijbiomac.2025.145410_bb0100","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2021571118","article-title":"A spatial model of YAP\/TAZ signaling reveals how stiffness, dimensionality, and shape contribute to emergent outcomes [J]","author":"Scott","year":"2021","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.145410_bb0105","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1186\/s12943-018-0882-1","article-title":"The role of YAP\/TAZ activity in cancer metabolic reprogramming [J]","volume":"17","author":"Zhang","year":"2018","journal-title":"Mol. Cancer"},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.145410_bb0110","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.tcb.2019.10.005","article-title":"The hippo pathway, YAP\/TAZ, and the plasma membrane [J]","volume":"30","author":"Rausch","year":"2020","journal-title":"Trends Cell Biol."},{"issue":"8","key":"10.1016\/j.ijbiomac.2025.145410_bb0115","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1038\/s41419-020-02822-1","article-title":"Caveolin1 and YAP drive mechanically induced mesothelial to mesenchymal transition and fibrosis [J]","volume":"11","author":"Strippoli","year":"2020","journal-title":"Cell Death Dis."},{"issue":"7720","key":"10.1016\/j.ijbiomac.2025.145410_bb0120","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1038\/s41586-018-0444-0","article-title":"RAP2 mediates mechanoresponses of the hippo pathway [J]","volume":"560","author":"Meng","year":"2018","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.ijbiomac.2025.145410_bb0125","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.cub.2018.11.066","article-title":"The hippo pathway regulates Caveolae expression and mediates flow response via Caveolae [J]","volume":"29","author":"Rausch","year":"2019","journal-title":"Curr. Biol."},{"issue":"4","key":"10.1016\/j.ijbiomac.2025.145410_bb0130","doi-asserted-by":"crossref","first-page":"405","DOI":"10.20892\/j.issn.2095-3941.2017.0083","article-title":"Increased expression of YAP1 in prostate cancer correlates with extraprostatic extension [J]","volume":"14","author":"Collak","year":"2017","journal-title":"Cancer Biol. Med."},{"key":"10.1016\/j.ijbiomac.2025.145410_bb0135","article-title":"The hippo pathway in prostate Cancer [J]","volume":"8(4).doi:10.3390\/cells8040370","author":"Salem","year":"2019","journal-title":"Cells"},{"key":"10.1016\/j.ijbiomac.2025.145410_bb0140","doi-asserted-by":"crossref","DOI":"10.1016\/j.ceb.2024.102371","article-title":"The adaptable caveola coat generates a plasma membrane sensory system [J]","volume":"88","author":"Lundmark","year":"2024","journal-title":"Curr. Opin. Cell Biol."},{"issue":"3","key":"10.1016\/j.ijbiomac.2025.145410_bb0145","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1186\/gb-2004-5-3-214","article-title":"The caveolin proteins [J]","volume":"5","author":"Williams","year":"2004","journal-title":"Genome Biol."},{"issue":"4","key":"10.1016\/j.ijbiomac.2025.145410_bb0150","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1152\/physrev.00046.2003","article-title":"Role of caveolae and caveolins in health and disease [J]","volume":"84","author":"Cohen","year":"2004","journal-title":"Physiol. Rev."},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.145410_bb0155","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1038\/s42003-023-05693-2","article-title":"The Cavin-1\/Caveolin-1 interaction attenuates BMP\/Smad signaling in pulmonary hypertension by interfering with BMPR2\/Caveolin-1 binding [J]","volume":"7","author":"Tomita","year":"2024","journal-title":"Commun Biol"},{"issue":"3","key":"10.1016\/j.ijbiomac.2025.145410_bb0160","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/S0169-409X(01)00145-4","article-title":"Caveolae and the caveolins in human disease [J]","volume":"49","author":"Campbell","year":"2001","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"5","key":"10.1016\/j.ijbiomac.2025.145410_bb0165","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0126056","article-title":"Galectin-3 overrides PTRF\/Cavin-1 reduction of PC3 prostate Cancer cell migration [J]","volume":"10","author":"Meng","year":"2015","journal-title":"PLoS One"},{"issue":"13","key":"10.1016\/j.ijbiomac.2025.145410_bb0170","doi-asserted-by":"crossref","first-page":"2151","DOI":"10.4161\/cc.10.13.16234","article-title":"Caveolin-2-deficient mice show increased sensitivity to endotoxemia [J]","volume":"10","author":"De Almeida","year":"2011","journal-title":"Cell Cycle"},{"key":"10.1016\/j.ijbiomac.2025.145410_bb0175","doi-asserted-by":"crossref","first-page":"1530","DOI":"10.3389\/fimmu.2017.01530","article-title":"Caveolin-1 and Caveolin-2 can be antagonistic Partners in Inflammation and beyond [J]","volume":"8","author":"De Almeida","year":"2017","journal-title":"Front. Immunol."},{"issue":"4","key":"10.1016\/j.ijbiomac.2025.145410_bb0180","doi-asserted-by":"crossref","first-page":"4966","DOI":"10.1002\/jcb.27772","article-title":"Novel finding of caveolin-2 in apical membranes of proximal tubule and first detection of caveolin-2 in urine: a promising biomarker of renal disease [J]","volume":"120","author":"Bulacio","year":"2019","journal-title":"J. Cell. Biochem."},{"issue":"8","key":"10.1016\/j.ijbiomac.2025.145410_bb0185","doi-asserted-by":"crossref","first-page":"2583","DOI":"10.1016\/j.ekir.2024.06.012","article-title":"Corrigendum to \u201cWCN24-2499 CAVEOLIN-1 AND CAVEOLIN-2 AS POTENTIAL URINARY EARLY BIOMARKERS OF RENAL INJURY IN ACUTE CHOLESTASIS IN RATS\u201d [kidney international reports volume 9, issue 4, supplement, April 2024, page S541] [J]","volume":"9","author":"Brandoni","year":"2024","journal-title":"Kidney Int Rep"},{"issue":"15","key":"10.1016\/j.ijbiomac.2025.145410_bb0190","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1161\/CIRCULATIONAHA.122.063073","article-title":"Nitrative modification of Caveolin-3: a novel mechanism of cardiac insulin resistance and a potential therapeutic target against ischemic heart failure in Prediabetic animals [J]","volume":"147","author":"Meng","year":"2023","journal-title":"Circulation"},{"key":"10.1016\/j.ijbiomac.2025.145410_bb0195","doi-asserted-by":"crossref","DOI":"10.1016\/j.preteyeres.2022.101094","article-title":"Caveolar and non-Caveolar Caveolin-1 in ocular homeostasis and disease [J]","volume":"91","author":"Enyong","year":"2022","journal-title":"Prog. Retin. Eye Res."},{"issue":"11","key":"10.1016\/j.ijbiomac.2025.145410_bb0200","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1111\/j.1600-0854.2007.00640.x","article-title":"Annexin A6-induced alterations in cholesterol transport and caveolin export from the Golgi complex [J]","volume":"8","author":"Cubells","year":"2007","journal-title":"Traffic"},{"issue":"2","key":"10.1016\/j.ijbiomac.2025.145410_bb0205","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.acthis.2018.10.008","article-title":"Caveolin-1 is related to lipid droplet formation in hepatic stellate cells in human liver [J]","volume":"121","author":"Yokomori","year":"2019","journal-title":"Acta Histochem."},{"issue":"2","key":"10.1016\/j.ijbiomac.2025.145410_bb0210","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1007\/s10555-020-09875-w","article-title":"Caveolin-1, a master regulator of cellular senescence [J]","volume":"39","author":"Volonte","year":"2020","journal-title":"Cancer Metastasis Rev."},{"issue":"8","key":"10.1016\/j.ijbiomac.2025.145410_bb0215","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1038\/s41419-020-02792-4","article-title":"Caveolin-1 suppresses tumor formation through the inhibition of the unfolded protein response [J]","volume":"11","author":"D\u00edaz","year":"2020","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.ijbiomac.2025.145410_bb0220","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2022.102304","article-title":"Caveolin-1 controls mitochondrial damage and ROS production by regulating fission - fusion dynamics and mitophagy [J]","volume":"52","author":"Jiang","year":"2022","journal-title":"Redox Biol."},{"key":"10.1016\/j.ijbiomac.2025.145410_bb0225","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2023130118","article-title":"Caveolar peroxynitrite formation impairs endothelial TRPV4 channels and elevates pulmonary arterial pressure in pulmonary hypertension [J]","author":"Daneva","year":"2021","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ijbiomac.2025.145410_bb0230","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2022.154117","article-title":"Isoliquiritigenin alleviates liver fibrosis through caveolin-1-mediated hepatic stellate cells ferroptosis in zebrafish and mice [J]","volume":"101","author":"Huang","year":"2022","journal-title":"Phytomedicine"},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.145410_bb0235","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1111\/jcmm.17045","article-title":"Caveolin-1 negatively regulates inflammation and fibrosis in silicosis [J]","volume":"26","author":"He","year":"2022","journal-title":"J. Cell. Mol. Med."},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.145410_bb0240","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1186\/s12964-023-01328-5","article-title":"Neuron-targeted overexpression of caveolin-1 alleviates diabetes-associated cognitive dysfunction via regulating mitochondrial fission-mitophagy axis [J]","volume":"21","author":"Tang","year":"2023","journal-title":"Cell Commun. Signal"},{"key":"10.1016\/j.ijbiomac.2025.145410_bb0245","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2020.101116","article-title":"Deciphering the roles of caveolin in neurodegenerative diseases: the good, the bad and the importance of context [J]","volume":"62","author":"Yang","year":"2020","journal-title":"Ageing Res. Rev."},{"issue":"11","key":"10.1016\/j.ijbiomac.2025.145410_bb0250","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1080\/15384101.2023.2206502","article-title":"Basal epithelial cells in prostate development, tumorigenesis, and cancer progression [J]","volume":"22","author":"Pitzen","year":"2023","journal-title":"Cell Cycle"},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.145410_bb0255","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.jnci.2017.01.002","article-title":"Prognostic significance of epithelial\/stromal caveolin-1 expression in prostatic hyperplasia, high grade prostatic intraepithelial hyperplasia and prostatic carcinoma and its correlation with microvessel density [J]","volume":"29","author":"Mohammed","year":"2017","journal-title":"J. Egypt. Natl. Canc. Inst."},{"issue":"27","key":"10.1016\/j.ijbiomac.2025.145410_bb0260","doi-asserted-by":"crossref","first-page":"3561","DOI":"10.1038\/onc.2013.315","article-title":"PTRF\/cavin-1 neutralizes non-caveolar caveolin-1 microdomains in prostate cancer [J]","volume":"33","author":"Moon","year":"2014","journal-title":"Oncogene"},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.145410_bb0265","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1002\/path.4217","article-title":"Loss of caveolin-1 in prostate cancer stroma correlates with reduced relapse-free survival and is functionally relevant to tumour progression [J]","volume":"231","author":"Ayala","year":"2013","journal-title":"J. Pathol."},{"issue":"10","key":"10.1016\/j.ijbiomac.2025.145410_bb0270","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0164016","article-title":"High Caveolin-1 expression in tumor stroma is associated with a Favourable outcome in prostate Cancer patients managed by watchful waiting [J]","volume":"11","author":"Hammarsten","year":"2016","journal-title":"PLoS One"},{"issue":"15","key":"10.1016\/j.ijbiomac.2025.145410_bb0275","doi-asserted-by":"crossref","first-page":"2420","DOI":"10.4161\/cc.8.15.9116","article-title":"An absence of stromal caveolin-1 is associated with advanced prostate cancer, metastatic disease and epithelial Akt activation [J]","volume":"8","author":"Di Vizio","year":"2009","journal-title":"Cell Cycle"},{"issue":"9","key":"10.1016\/j.ijbiomac.2025.145410_bb0280","doi-asserted-by":"crossref","first-page":"2200","DOI":"10.1080\/15548627.2020.1820787","article-title":"An inverted CAV1 (caveolin 1) topology defines novel autophagy-dependent exosome secretion from prostate cancer cells [J]","volume":"17","author":"Ariotti","year":"2021","journal-title":"Autophagy"},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.145410_bb0285","doi-asserted-by":"crossref","first-page":"4279","DOI":"10.1038\/s41467-020-17645-z","article-title":"Caveolin-1-mediated sphingolipid oncometabolism underlies a metabolic vulnerability of prostate cancer [J]","volume":"11","author":"Vykoukal","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ijbiomac.2025.145410_bb0290","article-title":"Exosomal prostate-specific membrane antigen (PSMA) and Caveolin-1 as potential biomarkers of prostate Cancer-evidence from Serbian population [J]","volume":"25(6).doi:10.3390\/ijms25063533","author":"Matija\u0161evi\u0107 Jokovi\u0107","year":"2024","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.145410_bb0295","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1111\/bju.13963","article-title":"Baseline and longitudinal plasma caveolin-1 level as a biomarker in active surveillance for early-stage prostate cancer [J]","volume":"121","author":"Basourakos","year":"2018","journal-title":"BJU Int."},{"issue":"3","key":"10.1016\/j.ijbiomac.2025.145410_bb0300","first-page":"831","article-title":"Caveolin-1 as a potential high-risk prostate cancer biomarker [J]","volume":"27","author":"Gumulec","year":"2012","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.ijbiomac.2025.145410_bb0305","doi-asserted-by":"crossref","first-page":"9091","DOI":"10.2147\/IJN.S447645","article-title":"Silver nanoparticles (AgNPs) uptake by Caveolae-dependent endocytosis is responsible for their selective effect towards castration resistant prostate Cancer [J]","volume":"19","author":"Morais","year":"2024","journal-title":"Int. J. Nanomedicine"},{"issue":"6","key":"10.1016\/j.ijbiomac.2025.145410_bb0310","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1038\/onc.2017.385","article-title":"Reactivation of androgen receptor-regulated lipid biosynthesis drives the progression of castration-resistant prostate cancer [J]","volume":"37","author":"Han","year":"2018","journal-title":"Oncogene"},{"key":"10.1016\/j.ijbiomac.2025.145410_bb0315","article-title":"AR and PI3K\/AKT in prostate Cancer: a tale of two interconnected pathways [J]","volume":"24(3).doi:10.3390\/ijms24032046","author":"Tortorella","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.145410_bb0320","doi-asserted-by":"crossref","first-page":"7675","DOI":"10.1038\/s41467-024-52032-y","article-title":"Androgen receptor monomers and dimers regulate opposing biological processes in prostate cancer cells [J]","volume":"15","author":"Safi","year":"2024","journal-title":"Nat. Commun."},{"issue":"5","key":"10.1016\/j.ijbiomac.2025.145410_bb0325","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1002\/hep.32120","article-title":"Phosphorylation of androgen receptor by mTORC1 promotes liver steatosis and tumorigenesis [J]","volume":"75","author":"Ren","year":"2022","journal-title":"Hepatology"},{"issue":"5","key":"10.1016\/j.ijbiomac.2025.145410_bb0330","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1007\/s13402-022-00706-4","article-title":"Dual contribution of the mTOR pathway and of the metabolism of amino acids in prostate cancer [J]","volume":"45","author":"Schcolnik-Cabrera","year":"2022","journal-title":"Cell. Oncol. (Dordr)"},{"issue":"7","key":"10.1016\/j.ijbiomac.2025.145410_bb0335","doi-asserted-by":"crossref","DOI":"10.3390\/cancers16071313","article-title":"Targeting dysregulated lipid metabolism in Cancer with pharmacological inhibitors [J]","volume":"16","author":"Gupta","year":"2024","journal-title":"Cancers (Basel)"},{"issue":"3","key":"10.1016\/j.ijbiomac.2025.145410_bb0340","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.ajur.2019.12.003","article-title":"Lipogenic effects of androgen signaling in normal and malignant prostate [J]","volume":"7","author":"Mah","year":"2020","journal-title":"Asian J Urol"},{"issue":"S4","key":"10.1016\/j.ijbiomac.2025.145410_bb0345","doi-asserted-by":"crossref","first-page":"1","DOI":"10.33594\/000000592","article-title":"Cholesterol triggers nuclear co-Association of Androgen Receptor, p160 steroid coactivators, and p300\/CBP-associated factor leading to androgenic Axis transactivation in castration-resistant prostate Cancer [J]","volume":"56","author":"Pimenta","year":"2022","journal-title":"Cell. Physiol. Biochem."},{"issue":"6","key":"10.1016\/j.ijbiomac.2025.145410_bb0350","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1007\/s00418-023-02183-8","article-title":"Opposite changes in the expression of clathrin and caveolin-1 in normal and cancerous human prostate tissue: putative clathrin-mediated recycling of EGFR [J]","volume":"159","author":"Xie","year":"2023","journal-title":"Histochem. Cell Biol."},{"issue":"4","key":"10.1016\/j.ijbiomac.2025.145410_bb0355","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1038\/s41419-020-2418-z","article-title":"Caveolin-1 regulates the ASMase\/ceramide-mediated radiation response of endothelial cells in the context of tumor-stroma interactions [J]","volume":"11","author":"Ketteler","year":"2020","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.ijbiomac.2025.145410_bb0360","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.802482","article-title":"Stromal fibroblasts counteract the Caveolin-1-dependent radiation response of LNCaP prostate carcinoma cells [J]","volume":"12","author":"Wittka","year":"2022","journal-title":"Front. Oncol."},{"issue":"11","key":"10.1016\/j.ijbiomac.2025.145410_bb0365","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1038\/s41419-019-2066-3","article-title":"The paracrine induction of prostate cancer progression by caveolin-1 [J]","volume":"10","author":"Lin","year":"2019","journal-title":"Cell Death Dis."},{"issue":"6","key":"10.1016\/j.ijbiomac.2025.145410_bb0370","first-page":"2054","article-title":"Simvastatin delays castration-resistant prostate cancer metastasis and androgen receptor antagonist resistance by regulating the expression of caveolin-1 [J]","volume":"54","author":"Gao","year":"2019","journal-title":"Int. J. Oncol."},{"issue":"6","key":"10.1016\/j.ijbiomac.2025.145410_bb0375","first-page":"391","article-title":"Significant Association of Caveolin-1 and Caveolin-2 with prostate Cancer progression [J]","volume":"12","author":"Sugie","year":"2015","journal-title":"Cancer Genomics Proteomics"},{"issue":"29","key":"10.1016\/j.ijbiomac.2025.145410_bb0380","doi-asserted-by":"crossref","first-page":"46321","DOI":"10.18632\/oncotarget.10113","article-title":"Caveolin-1 regulates hormone resistance through lipid synthesis, creating novel therapeutic opportunities for castration-resistant prostate cancer [J]","volume":"7","author":"Karantanos","year":"2016","journal-title":"Oncotarget"},{"issue":"4","key":"10.1016\/j.ijbiomac.2025.145410_bb0385","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1023\/A:1006110326366","article-title":"Metastasis-related genes in prostate cancer: the role of caveolin-1 [J]","volume":"17","author":"Thompson","year":"1998","journal-title":"Cancer Metastasis Rev."},{"issue":"9","key":"10.1016\/j.ijbiomac.2025.145410_bb0390","doi-asserted-by":"crossref","first-page":"eadi2742","DOI":"10.1126\/sciadv.adi2742","article-title":"Stat5 induces androgen receptor (AR) gene transcription in prostate cancer and offers a druggable pathway to target AR signaling [J]","volume":"10","author":"Maranto","year":"2024","journal-title":"Sci. Adv."},{"issue":"28","key":"10.1016\/j.ijbiomac.2025.145410_bb0395","doi-asserted-by":"crossref","first-page":"25631","DOI":"10.1074\/jbc.M202809200","article-title":"Dependence of selective gene activation on the androgen receptor NH2- and COOH-terminal interaction [J]","volume":"277","author":"He","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ijbiomac.2025.145410_bb0400","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2024.107234","article-title":"PROTACs targeting androgen receptor signaling: potential therapeutic agents for castration-resistant prostate cancer [J]","volume":"205","author":"Zhang","year":"2024","journal-title":"Pharmacol. Res."},{"issue":"26","key":"10.1016\/j.ijbiomac.2025.145410_bb0405","doi-asserted-by":"crossref","first-page":"4267","DOI":"10.1200\/JCO.23.00433","article-title":"Targeting the androgen signaling Axis in prostate Cancer [J]","volume":"41","author":"Dai","year":"2023","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ijbiomac.2025.145410_bb0410","doi-asserted-by":"crossref","DOI":"10.1016\/j.drup.2022.100905","article-title":"ABC transporters affects tumor immune microenvironment to regulate cancer immunotherapy and multidrug resistance [J]","volume":"66","author":"Fan","year":"2023","journal-title":"Drug Resist. Updat."},{"issue":"30","key":"10.1016\/j.ijbiomac.2025.145410_bb0415","doi-asserted-by":"crossref","first-page":"2055","DOI":"10.2217\/fon-2023-0227","article-title":"siRNA-based approaches for castration-resistant prostate cancer therapy targeting the androgen receptor signaling pathway [J]","volume":"19","author":"Yu","year":"2023","journal-title":"Future Oncol."},{"issue":"2","key":"10.1016\/j.ijbiomac.2025.145410_bb0420","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1093\/nar\/gkad1126","article-title":"Chromatin accessibility and pioneer factor FOXA1 restrict glucocorticoid receptor action in prostate cancer [J]","volume":"52","author":"Helminen","year":"2024","journal-title":"Nucleic Acids Res."},{"issue":"8","key":"10.1016\/j.ijbiomac.2025.145410_bb0425","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2023.112937","article-title":"ASCL1 is activated downstream of the ROR2\/CREB signaling pathway to support lineage plasticity in prostate cancer [J]","volume":"42","author":"Tabrizian","year":"2023","journal-title":"Cell Rep."},{"issue":"13","key":"10.1016\/j.ijbiomac.2025.145410_bb0430","doi-asserted-by":"crossref","first-page":"7740","DOI":"10.1093\/nar\/gkae547","article-title":"ONECUT2 acts as a lineage plasticity driver in adenocarcinoma as well as neuroendocrine variants of prostate cancer [J]","volume":"52","author":"Qian","year":"2024","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.ijbiomac.2025.145410_bb0435","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.62592","article-title":"A feedback loop between the androgen receptor and 6-phosphogluoconate dehydrogenase (6PGD) drives prostate cancer growth [J]","volume":"10","author":"Gillis","year":"2021","journal-title":"Elife"},{"issue":"8","key":"10.1016\/j.ijbiomac.2025.145410_bb0440","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/j.tcb.2023.05.011","article-title":"Autocrine amphiregulin signaling sustains castration-resistant Ly6d(+) prostate cancer cells [J]","volume":"33","author":"Xin","year":"2023","journal-title":"Trends Cell Biol."},{"issue":"16","key":"10.1016\/j.ijbiomac.2025.145410_bb0445","doi-asserted-by":"crossref","first-page":"13442","DOI":"10.1074\/jbc.M006598200","article-title":"Caveolin-1 interacts with androgen receptor. A positive modulator of androgen receptor mediated transactivation [J]","volume":"276","author":"Lu","year":"2001","journal-title":"J. Biol. Chem."},{"issue":"9","key":"10.1016\/j.ijbiomac.2025.145410_bb0450","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1016\/j.biocel.2011.04.019","article-title":"Caveolin-1 overexpression enhances androgen-dependent growth and proliferation in the mouse prostate [J]","volume":"43","author":"Bryant","year":"2011","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/j.ijbiomac.2025.145410_bb0455","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.mce.2017.02.005","article-title":"Testosterone promotes tube formation of endothelial cells isolated from veins via activation of Smad1 protein [J]","volume":"446","author":"Liu","year":"2017","journal-title":"Mol. Cell. Endocrinol."},{"issue":"11","key":"10.1016\/j.ijbiomac.2025.145410_bb0460","first-page":"4386","article-title":"Caveolin-1 mediates testosterone-stimulated survival\/clonal growth and promotes metastatic activities in prostate cancer cells [J]","volume":"61","author":"Li","year":"2001","journal-title":"Cancer Res."},{"issue":"5","key":"10.1016\/j.ijbiomac.2025.145410_bb0465","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1002\/pros.22767","article-title":"Expression profiles and functional associations of endogenous androgen receptor and caveolin-1 in prostate cancer cell lines [J]","volume":"74","author":"Bennett","year":"2014","journal-title":"Prostate"},{"key":"10.1016\/j.ijbiomac.2025.145410_bb0470","doi-asserted-by":"crossref","DOI":"10.1016\/j.envres.2021.112235","article-title":"Effects and underlying cellular pathway involved in the impairment of the neurovascular unit following exposure of adult male mice to low doses of di(2-ethylhexyl) phthalate alone or in an environmental phthalate mixture [J]","volume":"207","author":"Ahmadpour","year":"2022","journal-title":"Environ. Res."},{"issue":"19","key":"10.1016\/j.ijbiomac.2025.145410_bb0475","doi-asserted-by":"crossref","first-page":"E3816","DOI":"10.1073\/pnas.1702211114","article-title":"Estrogen receptor \u03b2, a regulator of androgen receptor signaling in the mouse ventral prostate [J]","volume":"114","author":"Wu","year":"2017","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ijbiomac.2025.145410_bb0480","article-title":"Hesperidin suppresses the proliferation of prostate Cancer cells by inducing oxidative stress and disrupting ca(2+)","volume":"11(9).doi:10.3390\/antiox11091633","author":"Jeong","year":"2022","journal-title":"Homeostasis [J]. Antioxidants (Basel)"},{"issue":"5","key":"10.1016\/j.ijbiomac.2025.145410_bb0485","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1038\/s44318-024-00040-5","article-title":"Sterile inflammation via TRPM8 RNA-dependent TLR3-NF-kB\/IRF3 activation promotes antitumor immunity in prostate cancer [J]","volume":"43","author":"Alaimo","year":"2024","journal-title":"EMBO J."},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.145410_bb0490","doi-asserted-by":"crossref","first-page":"7281","DOI":"10.1038\/s41467-022-34871-9","article-title":"ARID1A loss induces polymorphonuclear myeloid-derived suppressor cell chemotaxis and promotes prostate cancer progression [J]","volume":"13","author":"Li","year":"2022","journal-title":"Nat. Commun."},{"issue":"2","key":"10.1016\/j.ijbiomac.2025.145410_bb0495","first-page":"101","article-title":"Comparison of sexual behavior and inflammatory parameters in prostate Cancer patients with control group: prospective controlled study [J]","volume":"19","author":"Benli","year":"2022","journal-title":"Urol. J."},{"issue":"10","key":"10.1016\/j.ijbiomac.2025.145410_bb0500","doi-asserted-by":"crossref","first-page":"3771","DOI":"10.1007\/s00345-021-03715-4","article-title":"Role of systemic immune-inflammation index in patients treated with salvage radical prostatectomy [J]","volume":"39","author":"Rajwa","year":"2021","journal-title":"World. J. Urol."},{"key":"10.1016\/j.ijbiomac.2025.145410_bb0505","doi-asserted-by":"crossref","DOI":"10.1016\/j.ecoenv.2020.111436","article-title":"ROS-mediated genotoxic stress is involved in NaAsO(2)-induced cell cycle arrest, stemness enhancement and chemoresistance of prostate cancer cells in a p53-independent manner [J]","volume":"208","author":"Zhang","year":"2021","journal-title":"Ecotoxicol. Environ. Saf."},{"key":"10.1016\/j.ijbiomac.2025.145410_bb0510","series-title":"Discovery of the PTEN Tumor Suppressor and its Connection to the PI3K and AKT Oncogenes [J]","author":"Parsons","year":"2020"},{"issue":"4","key":"10.1016\/j.ijbiomac.2025.145410_bb0515","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0154210","article-title":"Caveolin-1 expression ameliorates nephrotic damage in a rabbit model of cholesterol-induced hypercholesterolemia [J]","volume":"11","author":"Chen","year":"2016","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.ijbiomac.2025.145410_bb0520","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1007\/s12035-021-02644-y","article-title":"Cav-1 protein levels in serum and infarcted brain correlate with hemorrhagic volume in a mouse model of thromboembolic stroke, independently of rt-PA Administration [J]","volume":"59","author":"Gubern-M\u00e9rida","year":"2022","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.ijbiomac.2025.145410_bb0525","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1146\/annurev-pathol-011811-120856","article-title":"Caveolin-1 and cancer metabolism in the tumor microenvironment: markers, models, and mechanisms [J]","volume":"7","author":"Sotgia","year":"2012","journal-title":"Annu. Rev. Pathol."},{"issue":"2","key":"10.1016\/j.ijbiomac.2025.145410_bb0530","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1080\/09553002.2023.2263553","article-title":"Docetaxel radiosensitizes castration-resistant prostate cancer by downregulating CAV-1 [J]","volume":"100","author":"Tu","year":"2024","journal-title":"Int. J. Radiat. Biol."},{"issue":"7","key":"10.1016\/j.ijbiomac.2025.145410_bb0535","doi-asserted-by":"crossref","first-page":"2502","DOI":"10.1091\/mbc.01-11-0529","article-title":"Expression of caveolin-1 induces premature cellular senescence in primary cultures of murine fibroblasts [J]","volume":"13","author":"Volonte","year":"2002","journal-title":"Mol. Biol. Cell"},{"issue":"2","key":"10.1016\/j.ijbiomac.2025.145410_bb0540","first-page":"C235","article-title":"Hydrogen peroxide inhibits non-small cell lung cancer cell anoikis through the inhibition of caveolin-1 degradation [J]","volume":"300","author":"Rungtabnapa","year":"2011","journal-title":"Am. J. Phys. Cell Phys."},{"issue":"11","key":"10.1016\/j.ijbiomac.2025.145410_bb0545","doi-asserted-by":"crossref","first-page":"7481","DOI":"10.1074\/jbc.275.11.7481","article-title":"Epidermal growth factor-stimulated tyrosine phosphorylation of caveolin-1. Enhanced caveolin-1 tyrosine phosphorylation following aberrant epidermal growth factor receptor status [J]","volume":"275","author":"Kim","year":"2000","journal-title":"J. Biol. Chem."},{"issue":"2","key":"10.1016\/j.ijbiomac.2025.145410_bb0550","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1006\/excr.1999.4792","article-title":"Caveolin internalization by heat shock or hyperosmotic shock [J]","volume":"255","author":"Kang","year":"2000","journal-title":"Exp. Cell Res."},{"issue":"2","key":"10.1016\/j.ijbiomac.2025.145410_bb0555","first-page":"483","article-title":"Caveolin-1 attenuates hydrogen peroxide-induced oxidative damage to lung carcinoma cells [J]","volume":"32","author":"Suchaoin","year":"2012","journal-title":"Anticancer Res."},{"issue":"5","key":"10.1016\/j.ijbiomac.2025.145410_bb0560","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.7150\/thno.79250","article-title":"Tumor-derived Cav-1 promotes pre-metastatic niche formation and lung metastasis in breast cancer [J]","volume":"13","author":"Wang","year":"2023","journal-title":"Theranostics"},{"key":"10.1016\/j.ijbiomac.2025.145410_bb0565","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.biopha.2018.03.016","article-title":"Cav-1 deficiency promotes liver fibrosis in carbon tetrachloride (CCl(4))-induced mice by regulation of oxidative stress and inflammation responses [J]","volume":"102","author":"Ji","year":"2018","journal-title":"Biomed. Pharmacother."},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.145410_bb0570","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.cell.2016.06.028","article-title":"EMT: 2016 [j]","volume":"166","author":"Nieto","year":"2016","journal-title":"Cell"},{"key":"10.1016\/j.ijbiomac.2025.145410_bb0575","article-title":"Phenotypic plasticity and Cancer: a system biology perspective [J]","volume":"13(15).doi:10.3390\/jcm13154302","author":"Subbalakshmi","year":"2024","journal-title":"J. Clin. Med."},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.145410_bb0580","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1111\/j.1464-410X.2012.11551.x","article-title":"Expression patterns of epithelial-mesenchymal transition markers in localized prostate cancer: significance in clinicopathological outcomes following radical prostatectomy [J]","volume":"111","author":"Behnsawy","year":"2013","journal-title":"BJU Int."},{"key":"10.1016\/j.ijbiomac.2025.145410_bb0585","article-title":"Deciphering the molecular machinery-influence of sE-cadherin on tumorigenic traits of prostate Cancer cells [J]","author":"Tsaur","year":"2021","journal-title":"Biology (Basel)"},{"issue":"11","key":"10.1016\/j.ijbiomac.2025.145410_bb0590","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1016\/j.neo.2021.09.005","article-title":"CKB inhibits epithelial-mesenchymal transition and prostate cancer progression by sequestering and inhibiting AKT activation [J]","volume":"23","author":"Wang","year":"2021","journal-title":"Neoplasia"},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.145410_bb0595","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.ejca.2013.08.016","article-title":"Caveolin-1 promotes gastric cancer progression by up-regulating epithelial to mesenchymal transition by crosstalk of signalling mechanisms under hypoxic condition [J]","volume":"50","author":"Kannan","year":"2014","journal-title":"Eur. J. Cancer"},{"issue":"8","key":"10.1016\/j.ijbiomac.2025.145410_bb0600","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1016\/j.biopha.2014.10.005","article-title":"Curcumin ameliorates epithelial-to-mesenchymal transition of podocytes in vivo and in vitro via regulating caveolin-1 [J]","volume":"68","author":"Sun","year":"2014","journal-title":"Biomed. Pharmacother."},{"issue":"11","key":"10.1016\/j.ijbiomac.2025.145410_bb0605","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.3724\/abbs.2022150","article-title":"Caveolin-1-deficient fibroblasts promote migration, invasion, and stemness via activating the TGF-\u03b2\/Smad signaling pathway in breast cancer cells [J]","volume":"54","author":"Huang","year":"2022","journal-title":"Acta Biochim. Biophys. Sin. Shanghai"},{"key":"10.1016\/j.ijbiomac.2025.145410_bb0610","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1186\/s12935-019-0892-0","article-title":"Caveolin-1 enhances brain metastasis of non-small cell lung cancer, potentially in association with the epithelial-mesenchymal transition marker SNAIL [J]","volume":"19","author":"Kim","year":"2019","journal-title":"Cancer Cell Int."},{"issue":"20","key":"10.1016\/j.ijbiomac.2025.145410_bb0615","doi-asserted-by":"crossref","first-page":"13714","DOI":"10.1074\/jbc.M709329200","article-title":"Caveolin-1 up-regulation during epithelial to mesenchymal transition is mediated by focal adhesion kinase [J]","volume":"283","author":"Bailey","year":"2008","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.145410_bb0620","doi-asserted-by":"crossref","first-page":"292","DOI":"10.2353\/ajpath.2006.050429","article-title":"Caveolin-1 deficiency (\u2212\/\u2212) conveys premalignant alterations in mammary epithelia, with abnormal lumen formation, growth factor independence, and cell invasiveness [J]","volume":"168","author":"Sotgia","year":"2006","journal-title":"Am. J. Pathol."},{"issue":"6","key":"10.1016\/j.ijbiomac.2025.145410_bb0625","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/S1535-6108(03)00304-0","article-title":"Downregulation of caveolin-1 function by EGF leads to the loss of E-cadherin, increased transcriptional activity of beta-catenin, and enhanced tumor cell invasion [J]","volume":"4","author":"Lu","year":"2003","journal-title":"Cancer Cell"},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.145410_bb0630","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1167\/iovs.16-20513","article-title":"Role of Caveolin-1 for blocking the epithelial-mesenchymal transition in proliferative vitreoretinopathy [J]","volume":"58","author":"Nagasaka","year":"2017","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.145410_bb0635","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1080\/15384047.2018.1507256","article-title":"ELF3 is an antagonist of oncogenic-signalling-induced expression of EMT-TF ZEB1 [J]","volume":"20","author":"Liu","year":"2019","journal-title":"Cancer Biol. Ther."},{"issue":"2","key":"10.1016\/j.ijbiomac.2025.145410_bb0640","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2024.e24464","article-title":"Caveolin-1 promotes glioma proliferation and metastasis by enhancing EMT via mediating PAI-1 activation and its correlation with immune infiltrates [J]","volume":"10","author":"Wang","year":"2024","journal-title":"Heliyon"},{"issue":"2","key":"10.1016\/j.ijbiomac.2025.145410_bb0645","first-page":"1298","article-title":"Involvement of the TGF-\u03b21 pathway in caveolin-1-associated regulation of head and neck tumor cell metastasis [J]","volume":"19","author":"Sun","year":"2020","journal-title":"Oncol. Lett."},{"issue":"6","key":"10.1016\/j.ijbiomac.2025.145410_bb0650","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1016\/j.urolonc.2014.01.005","article-title":"CAV-1 contributes to bladder cancer progression by inducing epithelial-to-mesenchymal transition [J]","volume":"32","author":"Liang","year":"2014","journal-title":"Urol. Oncol."},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.145410_bb0655","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0084551","article-title":"Caveolin-1 is up-regulated by GLI1 and contributes to GLI1-driven EMT in hepatocellular carcinoma [J]","volume":"9","author":"Gai","year":"2014","journal-title":"PLoS One"},{"issue":"10","key":"10.1016\/j.ijbiomac.2025.145410_bb0660","doi-asserted-by":"crossref","first-page":"7421","DOI":"10.1007\/s00210-024-03153-0","article-title":"Targeting the autophagy-miRNA axis in prostate cancer: toward novel diagnostic and therapeutic strategies [J]","volume":"397","author":"Syed","year":"2024","journal-title":"Naunyn Schmiedebergs Arch. Pharmacol."},{"issue":"4","key":"10.1016\/j.ijbiomac.2025.145410_bb0665","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1158\/1078-0432.CCR-12-3114","article-title":"Blocked autophagy using lysosomotropic agents sensitizes resistant prostate tumor cells to the novel Akt inhibitor AZD5363 [J]","volume":"19","author":"Lamoureux","year":"2013","journal-title":"Clin. Cancer Res."},{"issue":"9","key":"10.1016\/j.ijbiomac.2025.145410_bb0670","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1038\/s41419-018-0866-5","article-title":"Dual role of autophagy on docetaxel-sensitivity in prostate cancer cells [J]","volume":"9","author":"Cristofani","year":"2018","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.ijbiomac.2025.145410_bb0675","article-title":"Novel insights into autophagy and prostate Cancer: a comprehensive review [J]","volume":"23(7).doi:10.3390\/ijms23073826","author":"Loizzo","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"11","key":"10.1016\/j.ijbiomac.2025.145410_bb0680","doi-asserted-by":"crossref","first-page":"13764","DOI":"10.3390\/ijms131113764","article-title":"Quantum dots-based immunofluorescent imaging of stromal fibroblasts Caveolin-1 and light chain 3B expression and identification of their clinical significance in human gastric cancer [J]","volume":"13","author":"He","year":"2012","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ijbiomac.2025.145410_bb0685","doi-asserted-by":"crossref","first-page":"46","DOI":"10.3389\/fonc.2020.00046","article-title":"Caveolin-1 promotes Chemoresistance of gastric Cancer cells to cisplatin by activating WNT\/\u03b2-catenin pathway [J]","volume":"10","author":"Wang","year":"2020","journal-title":"Front. Oncol."},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.145410_bb0690","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1186\/s13000-024-01511-3","article-title":"Rare histologic transformation of a CTNNB1 (\u03b2-catenin) mutated prostate cancer with aggressive clinical course [J]","volume":"19","author":"Akhoundova","year":"2024","journal-title":"Diagn. Pathol."},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.145410_bb0695","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1186\/s12964-025-02081-7","article-title":"ANO7 expression in the prostate modulates mitochondrial function and lipid metabolism [J]","volume":"23","author":"L\u00f6F","year":"2025","journal-title":"Cell Commun. Signal"},{"key":"10.1016\/j.ijbiomac.2025.145410_bb0700","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14174293","article-title":"Role of lipids and lipid metabolism in prostate Cancer progression and the tumor\u2019s immune environment [J]","author":"Siltari","year":"2022","journal-title":"Cancers (Basel)"},{"issue":"20","key":"10.1016\/j.ijbiomac.2025.145410_bb0705","doi-asserted-by":"crossref","first-page":"8133","DOI":"10.1158\/0008-5472.CAN-09-0775","article-title":"Novel lipogenic enzyme ELOVL7 is involved in prostate cancer growth through saturated long-chain fatty acid metabolism [J]","volume":"69","author":"Tamura","year":"2009","journal-title":"Cancer Res."},{"issue":"5","key":"10.1016\/j.ijbiomac.2025.145410_bb0710","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1038\/s41416-023-02557-8","article-title":"Peroxisomal \u03b2-oxidation enzyme, DECR2, regulates lipid metabolism and promotes treatment resistance in advanced prostate cancer [J]","volume":"130","author":"Mah","year":"2024","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.ijbiomac.2025.145410_bb0715","doi-asserted-by":"crossref","DOI":"10.1177\/17588359231152839","article-title":"Targeting lipid metabolism in metastatic prostate cancer [J]","volume":"15","author":"Scheinberg","year":"2023","journal-title":"Ther Adv Med Oncol"},{"issue":"20","key":"10.1016\/j.ijbiomac.2025.145410_bb0720","doi-asserted-by":"crossref","first-page":"6281","DOI":"10.1021\/acs.langmuir.1c03305","article-title":"Discrimination of receptor-mediated endocytosis by surface-enhanced Raman scattering [J]","volume":"38","author":"Yilmaz","year":"2022","journal-title":"Langmuir"},{"issue":"12","key":"10.1016\/j.ijbiomac.2025.145410_bb0725","doi-asserted-by":"crossref","first-page":"3063","DOI":"10.1158\/0008-5472.CAN-18-3295","article-title":"Cholesterol induces epithelial-to-mesenchymal transition of prostate Cancer cells by suppressing degradation of EGFR through APMAP [J]","volume":"79","author":"Jiang","year":"2019","journal-title":"Cancer Res."},{"issue":"8","key":"10.1016\/j.ijbiomac.2025.145410_bb0730","doi-asserted-by":"crossref","first-page":"2234","DOI":"10.1158\/0008-5472.CAN-20-1624","article-title":"Cytoplasmic localization of prostate-specific membrane antigen inhibitors may confer advantages for targeted Cancer therapies [J]","volume":"81","author":"Matthias","year":"2021","journal-title":"Cancer Res."},{"issue":"6","key":"10.1016\/j.ijbiomac.2025.145410_bb0735","doi-asserted-by":"crossref","first-page":"2070","DOI":"10.1158\/0008-5472.CAN-03-3645","article-title":"Orlistat is a novel inhibitor of fatty acid synthase with antitumor activity [J]","volume":"64","author":"Kridel","year":"2004","journal-title":"Cancer Res."},{"issue":"11","key":"10.1016\/j.ijbiomac.2025.145410_bb0740","doi-asserted-by":"crossref","first-page":"3834","DOI":"10.1002\/jcb.26033","article-title":"Anti-tumorigenic potential of a novel orlistat-AICAR combination in prostate Cancer cells [J]","volume":"118","author":"Wright","year":"2017","journal-title":"J. Cell. Biochem."},{"issue":"6","key":"10.1016\/j.ijbiomac.2025.145410_bb0745","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1038\/bjc.2012.355","article-title":"The fatty acid synthase inhibitor orlistat reduces experimental metastases and angiogenesis in B16-F10 melanomas [J]","volume":"107","author":"Seguin","year":"2012","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.ijbiomac.2025.145410_bb0750","article-title":"Effects of orlistat combined with enzalutamide and castration through inhibition of fatty acid synthase in a PC3 tumor-bearing mouse model [J]","volume":"41(5).doi:10.1042\/bsr20204203","author":"Tyan","year":"2021","journal-title":"Biosci. Rep."},{"issue":"4","key":"10.1016\/j.ijbiomac.2025.145410_bb0755","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.biopha.2011.02.016","article-title":"Antitumor effect of orlistat, a fatty acid synthase inhibitor, is via activation of caspase-3 on human colorectal carcinoma-bearing animal [J]","volume":"65","author":"Chuang","year":"2011","journal-title":"Biomed. Pharmacother."},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.145410_bb0760","doi-asserted-by":"crossref","first-page":"5222","DOI":"10.1038\/s41598-021-84538-6","article-title":"Pharmacological inhibition of tumor anabolism and host catabolism as a cancer therapy [J]","volume":"11","author":"Schcolnik-Cabrera","year":"2021","journal-title":"Sci. Rep."},{"issue":"11","key":"10.1016\/j.ijbiomac.2025.145410_bb0765","doi-asserted-by":"crossref","first-page":"1932","DOI":"10.1002\/oby.21970","article-title":"Caveolin-1 secreted from adipose tissues and adipocytes functions as an Adipogenesis enhancer [J]","volume":"25","author":"Chang","year":"2017","journal-title":"Obesity (Silver Spring)"},{"issue":"22","key":"10.1016\/j.ijbiomac.2025.145410_bb0770","doi-asserted-by":"crossref","first-page":"8594","DOI":"10.1158\/0008-5472.CAN-09-2305","article-title":"Lipid rafts and caveolin-1 are required for invadopodia formation and extracellular matrix degradation by human breast cancer cells [J]","volume":"69","author":"Yamaguchi","year":"2009","journal-title":"Cancer Res."},{"issue":"3","key":"10.1016\/j.ijbiomac.2025.145410_bb0775","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.3892\/or.2015.4511","article-title":"Caveolin-1 enhances RANKL-induced gastric cancer cell migration [J]","volume":"40","author":"Wang","year":"2018","journal-title":"Oncol. Rep."},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.145410_bb0780","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.biocel.2010.10.001","article-title":"Bleomycin treatment of A549 human lung cancer cells results in association of MGr1-ag and caveolin-1 in lipid rafts [J]","volume":"43","author":"Linge","year":"2011","journal-title":"Int. J. Biochem. Cell Biol."},{"issue":"3","key":"10.1016\/j.ijbiomac.2025.145410_bb0785","doi-asserted-by":"crossref","first-page":"887","DOI":"10.5114\/aoms\/174578","article-title":"Cinobufagin disrupts the stability of lipid rafts by inhibiting the expression of caveolin-1 to promote non-small cell lung cancer cell apoptosis [J]","volume":"20","author":"Xu","year":"2024","journal-title":"Arch. Med. Sci."},{"key":"10.1016\/j.ijbiomac.2025.145410_bb0790","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellsig.2024.111573","article-title":"Identification of AXL as a novel positive regulator of lipid raft in gastric cancer [J]","volume":"127","author":"Yang","year":"2025","journal-title":"Cell. Signal."},{"issue":"8","key":"10.1016\/j.ijbiomac.2025.145410_bb0795","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.4161\/cbt.6.8.4447","article-title":"Caveolin-1 is required for the upregulation of fatty acid synthase (FASN), a tumor promoter, during prostate cancer progression [J]","volume":"6","author":"Di Vizio","year":"2007","journal-title":"Cancer Biol. Ther."},{"issue":"20","key":"10.1016\/j.ijbiomac.2025.145410_bb0800","doi-asserted-by":"crossref","first-page":"10017","DOI":"10.18632\/oncotarget.2488","article-title":"Silibinin inhibits aberrant lipid metabolism, proliferation and emergence of androgen-independence in prostate cancer cells via primarily targeting the sterol response element binding protein 1 [J]","volume":"5","author":"Nambiar","year":"2014","journal-title":"Oncotarget"},{"issue":"3","key":"10.1016\/j.ijbiomac.2025.145410_bb0805","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/j.molonc.2014.11.006","article-title":"Obesity induced rapid melanoma progression is reversed by orlistat treatment and dietary intervention: role of adipokines [J]","volume":"9","author":"Malvi","year":"2015","journal-title":"Mol. Oncol."},{"issue":"11","key":"10.1016\/j.ijbiomac.2025.145410_bb0810","doi-asserted-by":"crossref","first-page":"2219","DOI":"10.1161\/ATVBAHA.110.213215","article-title":"ATP-binding cassette transporter G1 and high-density lipoprotein promote endothelial NO synthesis through a decrease in the interaction of caveolin-1 and endothelial NO synthase [J]","volume":"30","author":"Terasaka","year":"2010","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.ijbiomac.2025.145410_bb0815","doi-asserted-by":"crossref","first-page":"1442911","DOI":"10.3389\/fonc.2024.1442911","article-title":"FATP5 modulates biological activity and lipid metabolism in prostate cancer through the TEAD4-mediated hippo signaling [J]","volume":"14","author":"Liu","year":"2024","journal-title":"Front. Oncol."},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.145410_bb0820","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1186\/s12885-024-12018-x","article-title":"Gut microbiota in patients with prostate cancer: a systematic review and meta-analysis [J]","volume":"24","author":"Huang","year":"2024","journal-title":"BMC Cancer"},{"issue":"8","key":"10.1016\/j.ijbiomac.2025.145410_bb0825","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1111\/iju.14894","article-title":"Gut microbiome and prostate cancer [J]","volume":"29","author":"Fujita","year":"2022","journal-title":"Int. J. Urol."},{"issue":"6564","key":"10.1016\/j.ijbiomac.2025.145410_bb0830","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1126\/science.abf8403","article-title":"Commensal bacteria promote endocrine resistance in prostate cancer through androgen biosynthesis [J]","volume":"374","author":"Pernigoni","year":"2021","journal-title":"Science"},{"key":"10.1016\/j.ijbiomac.2025.145410_bb0835","series-title":"[J]. Cancer Discov","first-page":"2959","volume":"11","author":"Gut mMicrobiota dDrive aAndrogen rResistance in pProstate Cancer","year":"2021"},{"key":"10.1016\/j.ijbiomac.2025.145410_bb0840","doi-asserted-by":"crossref","DOI":"10.1016\/j.neo.2023.100928","article-title":"Gut microbiota-derived short-chain fatty acids promote prostate cancer progression via inducing cancer cell autophagy and M2 macrophage polarization [J]","volume":"43","author":"Liu","year":"2023","journal-title":"Neoplasia"},{"key":"10.1016\/j.ijbiomac.2025.145410_bb0845","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.890323","article-title":"Biotransformation of Abiraterone into five characteristic metabolites by the rat gut microbiota and liver Microsomes [J]","volume":"12","author":"Keranmu","year":"2022","journal-title":"Front. Oncol."},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.145410_bb0850","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1186\/s40168-022-01289-w","article-title":"Gut dysbiosis promotes prostate cancer progression and docetaxel resistance via activating NF-\u03baB-IL6-STAT3 axis [J]","volume":"10","author":"Zhong","year":"2022","journal-title":"Microbiome"},{"key":"10.1016\/j.ijbiomac.2025.145410_bb0855","article-title":"Microbiome and prostate Cancer","volume":"17(1).doi:10.3390\/ph17010112","author":"Kim","year":"2024","journal-title":"Emerging Diagnostic and Therapeutic Opportunities [J]. Pharmaceuticals (Basel)"},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.145410_bb0860","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1186\/s12967-024-05120-y","article-title":"Quinic acid regulated TMA\/TMAO-related lipid metabolism and vascular endothelial function through gut microbiota to inhibit atherosclerotic [J]","volume":"22","author":"Jin","year":"2024","journal-title":"J. Transl. Med."},{"issue":"15","key":"10.1016\/j.ijbiomac.2025.145410_bb0865","doi-asserted-by":"crossref","first-page":"4014","DOI":"10.1158\/0008-5472.CAN-20-4090","article-title":"Gut microbiota-derived short-chain fatty acids promote prostate Cancer growth via IGF1 signaling [J]","volume":"81","author":"Matsushita","year":"2021","journal-title":"Cancer Res."},{"key":"10.1016\/j.ijbiomac.2025.145410_bb0870","doi-asserted-by":"crossref","first-page":"819","DOI":"10.2147\/OTT.S123912","article-title":"The different functions and clinical significances of caveolin-1 in human adenocarcinoma and squamous cell carcinoma [J]","volume":"10","author":"Fu","year":"2017","journal-title":"Onco Targets Ther"},{"key":"10.1016\/j.ijbiomac.2025.145410_bb0875","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2024.117302","article-title":"The emerging role of the gut microbiota and its application in inflammatory bowel disease [J]","volume":"179","author":"Wang","year":"2024","journal-title":"Biomed. Pharmacother."},{"issue":"6","key":"10.1016\/j.ijbiomac.2025.145410_bb0880","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1111\/lam.13573","article-title":"Xinnaokang improves cecal microbiota and lipid metabolism to target atherosclerosis [J]","volume":"73","author":"Yang","year":"2021","journal-title":"Lett. Appl. Microbiol."},{"issue":"3","key":"10.1016\/j.ijbiomac.2025.145410_bb0885","doi-asserted-by":"crossref","DOI":"10.1111\/jcmm.18110","article-title":"Cav-1 regulates the bile salt export pump on the canalicular membrane of hepatocytes by PKC\u03b1-associated signalling under cholesterol stimulation [J]","volume":"28","author":"Pang","year":"2024","journal-title":"J. Cell. Mol. Med."},{"key":"10.1016\/j.ijbiomac.2025.145410_bb0890","doi-asserted-by":"crossref","first-page":"332","DOI":"10.12659\/MSM.907782","article-title":"Caveolin-1 inhibits proliferation, migration, and invasion of human colorectal Cancer cells by suppressing phosphorylation of epidermal growth factor receptor [J]","volume":"24","author":"Yang","year":"2018","journal-title":"Med. Sci. Monit."},{"issue":"1\u20132","key":"10.1016\/j.ijbiomac.2025.145410_bb0895","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/s11010-015-2429-8","article-title":"Baicalein inhibits prostate cancer cell growth and metastasis via the caveolin-1\/AKT\/mTOR pathway [J]","volume":"406","author":"Guo","year":"2015","journal-title":"Mol. Cell. Biochem."},{"key":"10.1016\/j.ijbiomac.2025.145410_bb0900","doi-asserted-by":"crossref","first-page":"1776","DOI":"10.1016\/j.biopha.2016.10.104","article-title":"Triptolide inhibits the migration and invasion of human prostate cancer cells via Caveolin-1\/CD147\/MMPs pathway [J]","volume":"84","author":"Yuan","year":"2016","journal-title":"Biomed. Pharmacother."},{"issue":"8","key":"10.1016\/j.ijbiomac.2025.145410_bb0905","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1002\/pros.22960","article-title":"\u0393-Oryzanol reduces caveolin-1 and PCGEM1 expression, markers of aggressiveness in prostate cancer cell lines [J]","volume":"75","author":"Hirsch","year":"2015","journal-title":"Prostate"},{"issue":"4b","key":"10.1016\/j.ijbiomac.2025.145410_bb0910","first-page":"2977","article-title":"Inhibition of caveolin-1 expression by incadronate in PC-3 prostate cells [J]","volume":"26","author":"Iguchi","year":"2006","journal-title":"Anticancer Res."},{"issue":"4","key":"10.1016\/j.ijbiomac.2025.145410_bb0915","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1038\/sj.neo.7900165","article-title":"Phenylbutyrate attenuates the expression of Bcl-X(L), DNA-PK, caveolin-1, and VEGF in prostate cancer cells [J]","volume":"3","author":"Goh","year":"2001","journal-title":"Neoplasia"},{"issue":"5","key":"10.1016\/j.ijbiomac.2025.145410_bb0920","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1097\/CAD.0000000000001306","article-title":"The marine factor 3,5-dihydroxy-4-methoxybenzyl alcohol suppresses growth, migration and invasion and stimulates death of metastatic human prostate cancer cells: targeting diverse signaling processes [J]","volume":"33","author":"Yamaguchi","year":"2022","journal-title":"Anti-Cancer Drugs"},{"issue":"2","key":"10.1016\/j.ijbiomac.2025.145410_bb0925","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1124\/mol.106.028696","article-title":"1,1-bis(3\u2032-indolyl)-1-(p-substitutedphenyl)methanes inhibit growth, induce apoptosis, and decrease the androgen receptor in LNCaP prostate cancer cells through peroxisome proliferator-activated receptor gamma-independent pathways [J]","volume":"71","author":"Chintharlapalli","year":"2007","journal-title":"Mol. Pharmacol."},{"issue":"6","key":"10.1016\/j.ijbiomac.2025.145410_bb0930","doi-asserted-by":"crossref","first-page":"2142","DOI":"10.3892\/ol.2014.2005","article-title":"Enhanced antitumor effects of low-frequency ultrasound and microbubbles in combination with simvastatin by downregulating caveolin-1 in prostatic DU145 cells [J]","volume":"7","author":"Xu","year":"2014","journal-title":"Oncol. Lett."},{"issue":"2","key":"10.1016\/j.ijbiomac.2025.145410_bb0935","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.canlet.2008.02.060","article-title":"Perifosine induces differentiation and cell death in prostate cancer cells [J]","volume":"266","author":"Floryk","year":"2008","journal-title":"Cancer Lett."},{"issue":"2","key":"10.1016\/j.ijbiomac.2025.145410_bb0940","doi-asserted-by":"crossref","first-page":"117","DOI":"10.4161\/cbt.22633","article-title":"Serum caveolin-1, a biomarker of drug response and therapeutic target in prostate cancer models [J]","volume":"14","author":"Tahir","year":"2013","journal-title":"Cancer Biol. Ther."},{"issue":"2","key":"10.1016\/j.ijbiomac.2025.145410_bb0945","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.bbrc.2020.02.086","article-title":"Involvement of Caveolin-1-mediated transcytosis in the intratumoral accumulation of liposomes [J]","volume":"525","author":"Sakurai","year":"2020","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"12","key":"10.1016\/j.ijbiomac.2025.145410_bb0950","doi-asserted-by":"crossref","first-page":"6217","DOI":"10.1039\/D4FO00614C","article-title":"Biological fate, functional properties, and design strategies for oral delivery systems for cinnamaldehyde [J]","volume":"15","author":"Weng","year":"2024","journal-title":"Food Funct."},{"issue":"14","key":"10.1016\/j.ijbiomac.2025.145410_bb0955","doi-asserted-by":"crossref","first-page":"6876","DOI":"10.1039\/D3NR05986C","article-title":"CaCO(3) nanoplatform for cancer treatment: drug delivery and combination therapy [J]","volume":"16","author":"Yang","year":"2024","journal-title":"Nanoscale"},{"key":"10.1016\/j.ijbiomac.2025.145410_bb0960","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/j.omto.2021.07.013","article-title":"A novel protein-drug conjugate, SSH20, demonstrates significant efficacy in caveolin-1-expressing tumors [J]","volume":"22","author":"Robb","year":"2021","journal-title":"Mol Ther Oncolytics"},{"issue":"23","key":"10.1016\/j.ijbiomac.2025.145410_bb0965","doi-asserted-by":"crossref","first-page":"2286","DOI":"10.4161\/cbt.8.23.10138","article-title":"Caveolin-1 regulates VEGF-stimulated angiogenic activities in prostate cancer and endothelial cells [J]","volume":"8","author":"Tahir","year":"2009","journal-title":"Cancer Biol. Ther."},{"issue":"26","key":"10.1016\/j.ijbiomac.2025.145410_bb0970","doi-asserted-by":"crossref","first-page":"25134","DOI":"10.1074\/jbc.M501186200","article-title":"Caveolin-1 promotes tumor progression in an autochthonous mouse model of prostate cancer: genetic ablation of Cav-1 delays advanced prostate tumor development in tramp mice [J]","volume":"280","author":"Williams","year":"2005","journal-title":"J. Biol. Chem."},{"issue":"16","key":"10.1016\/j.ijbiomac.2025.145410_bb0975","doi-asserted-by":"crossref","first-page":"4872","DOI":"10.1158\/1078-0432.CCR-06-0417","article-title":"Preoperative serum caveolin-1 as a prognostic marker for recurrence in a radical prostatectomy cohort [J]","volume":"12","author":"Tahir","year":"2006","journal-title":"Clin. Cancer Res."},{"issue":"2","key":"10.1016\/j.ijbiomac.2025.145410_bb0980","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1089\/hyb.2011.0100","article-title":"Anti-caveolin-1 antibodies as anti-prostate cancer therapeutics [J]","volume":"31","author":"Kuo","year":"2012","journal-title":"Hybridoma (Larchmt)"},{"issue":"12","key":"10.1016\/j.ijbiomac.2025.145410_bb0985","doi-asserted-by":"crossref","DOI":"10.1002\/jev2.12150","article-title":"Stroma-derived extracellular vesicle mRNA signatures inform histological nature of prostate cancer [J]","volume":"10","author":"Shephard","year":"2021","journal-title":"J Extracell Vesicles"},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.145410_bb0990","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1038\/s41585-024-00900-z","article-title":"Biological determinants of PSMA expression, regulation and heterogeneity in prostate cancer [J]","volume":"22","author":"Bakht","year":"2025","journal-title":"Nat. Rev. Urol."},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.145410_bb0995","first-page":"176","article-title":"Methylation pattern of caveolin-1 in prostate cancer as potential cfDNA biomarker [J]","volume":"23","author":"\u0160kara","year":"2023","journal-title":"Biomol Biomed"}],"container-title":["International Journal of Biological Macromolecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813025059653?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813025059653?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,8,5]],"date-time":"2025-08-05T15:07:10Z","timestamp":1754406430000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0141813025059653"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":199,"alternative-id":["S0141813025059653"],"URL":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2025.145410","relation":{},"ISSN":["0141-8130"],"issn-type":[{"value":"0141-8130","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Caveolin-1 in prostate Cancer: Novel insights and therapeutic opportunities\u2014A review","name":"articletitle","label":"Article Title"},{"value":"International Journal of Biological Macromolecules","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2025.145410","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"145410"}}